Lilly gets EU approval for Janssen buy; NZ to boost non-formulary drug spending;

@FiercePharma: GSK launches next revamp of sales rep pay. News | Follow @FiercePharma 

> Eli Lilly, only months away from losing patent protection for its top-selling drug, told investors that one key to overcoming this and other patent losses lies in emerging markets like China. Report

> Eli Lilly has secured EU regulatory approval to buy Johnson & Johnson's animal health unit Janssen to boost its presence in Europe. Item

> In a move expected to double spending in the first full year, New Zealand's drug agency PHARMAC is moving to a more "permissive" system of assessing people seeking medicines that are not funded on the Pharmaceutical Schedule. Piece

> Sanofi has launched its promising advanced prostate cancer drug Jevtana in the U.K. following EMA approval in March. Report

> GlaxoSmithKline is looking to get extended approval on both sides of the Atlantic for its kidney cancer drug Votrient to be also used for soft tissue sarcoma. Story

> Pfizer's Cox-2 inhibitor celecoxib, better known under the brand name Celebrex, might be able to prevent lung cancer in former smokers, researchers said. Article

> Common painkillers that treat inflammation have been linked to an increased risk of irregular heart rhythm in a study published in the British Medical Journal. Report

> Merck Serono tapped Belén Garijo to fill the newly created position of chief operating officer; Garijo has been Sanofi's SVP of Global Operations in the European region. News

Biotech News

@FierceBiotech:  Amgen teams with NASA on a new biotech space mission. Item | Follow @FierceBiotech 

@JohnCFierce: Here's the PR on Merck Serono R&D shakeup. 1st step: divide pre- and post-PoC into dedicated groups. Release | Follow @JohnCFierce

> Innate shares soar on record $465M antibody pact with BMS. Article 

> Merck Serono shakes up its R&D structure, brings in BMS vet. News 

> Zafgen banks $33M C round as it preps for Ph2 obesity study. Story

Vaccines News

> Inovio posts positive precinical HIV vax results. Report

> Medicago: PhII avian flu vax trial successful. News 

> Patient education needed for HPV vaccines, cancer screenings. Item 

> In final mission, space shuttle Atlantis carries vaccine research. Story 

> Funding supports Sorrento's staph infection work. Article

Manufacturing News 

> Regulator initiates EU-wide safety monitoring. Report 

> Novartis, Teva aid Russian police investigation. News 

> FDA bans Dr. Reddy's imports from Mexican plant. Article 

> Robotics seen as aid to re-shoring. Item 

> Tamiflu oral and Thyrogen updates on short supply list. News 

> Cadila cited for microorganism ID mishaps. Article 

And Finally... Liver cancers are embedded with a type of super cancer stem cells that make them resistant to chemotherapy, spread to other body parts and stage a comeback even after they are surgically removed, researchers said. Report

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.